Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV000626868 | SCV000747571 | pathogenic | Cavernous hemangioma | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000721907 | SCV000853059 | pathogenic | not provided | 2016-03-21 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Lab, |
RCV001007911 | SCV001167620 | pathogenic | Cerebral cavernous malformation | 2018-11-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001007911 | SCV001229905 | pathogenic | Cerebral cavernous malformation | 2021-03-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser301*) in the KRIT1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in several individuals with cerebral cavernous malformations (PMID: 10545614, 23595507, 24466005). This variant is also known as 281C>G, S94X in the literature. ClinVar contains an entry for this variant (Variation ID: 523476). Loss-of-function variants in KRIT1 are known to be pathogenic (PMID: 10508515, 11222804, 12404106, 24689081). For these reasons, this variant has been classified as Pathogenic. |
Centre for Mendelian Genomics, |
RCV001007911 | SCV001367653 | pathogenic | Cerebral cavernous malformation | 2020-03-15 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS4_MOD,PM2,PP4. |